Pan-cancer analysis revealed that up-regulation of SLC10A3 is not only a risk factor for worse overall survival among LGGs (Figure 3A), but also a risk factor for inferior progression-free survival among LGGs (Figure 3B). This evidence concerns the gene SLC10A3 and polyarteritis nodosa.